Leadership Overview
Renata Limited has 4 executives leading key functions including strategy, finance, marketing, and human resources.
Driven by a commitment to health and well-being, Renata Limited manufactures vital human pharmaceuticals and animal health products, impacting lives across Bangladesh and beyond with its dedication to quality and innovation.
Driven by a commitment to health and well-being, Renata Limited manufactures vital human pharmaceuticals and animal health products, impacting lives across Bangladesh and beyond with its dedication to quality and innovation.
Leadership Roles at Renata Limited
Kaiser Kabir - Chief Executive Officer
Kaiser Kabir, the Chief Executive Officer at Renata Limited, directs the company's overall strategic vision and operational execution. Overseeing all business units, Kaiser Kabir ensures alignment with the company's mission to provide high-quality pharmaceuticals and animal health products. This leadership role involves driving growth initiatives, optimizing resource allocation, and maintaining strong relationships with stakeholders across Bangladesh. By focusing on innovation and market expansion, Kaiser Kabir directly impacts Renata Limited's position as a leading manufacturer. Ultimately, Kabir secures the company's long-term financial health and market leadership through decisive strategic planning and effective management of the executive team.
Mustafa Aolad - Chief Financial Officer
Mustafa Aolad, the Chief Financial Officer at Renata Limited, manages all financial operations and strategic financial planning. Overseeing accounting, budgeting, and financial reporting, Mustafa Aolad ensures fiscal responsibility and drives profitability across the organization. This critical role involves analyzing market trends, managing investment strategies, and maintaining compliance with financial regulations in Bangladesh. By optimizing financial performance and managing risk, Aolad directly supports the company's expansion into new pharmaceutical and animal health product lines. Ultimately, Mustafa Aolad safeguards the company's financial stability and facilitates sustainable growth through expert financial oversight and strategic capital management.
Tanbir Sajib - Chief Marketing Officer, Renata Plc
Tanbir Sajib, the Chief Marketing Officer, Renata Plc at Renata Limited, spearheads all marketing and brand strategy initiatives. Overseeing market research, product positioning, and promotional campaigns, Tanbir Sajib drives demand for the company's diverse portfolio of human pharmaceuticals and animal health products. This leadership position involves identifying new market opportunities, developing effective go-to-market strategies, and ensuring consistent brand messaging across all platforms. By enhancing market penetration and customer engagement, Sajib directly contributes to revenue growth and strengthens Renata Limited's competitive edge. Ultimately, Tanbir Sajib elevates the company's market presence and fosters strong customer loyalty through innovative and data-driven marketing leadership.
Nisbat Anwar - Chief People Officer
Nisbat Anwar, the Chief People Officer at Renata Limited, directs all human resources functions and talent management strategies. Overseeing recruitment, employee development, and organizational culture, Nisbat Anwar ensures a highly skilled and motivated workforce to support the company's manufacturing and distribution of pharmaceuticals and animal health products. This pivotal role involves fostering a positive work environment, implementing effective HR policies, and aligning talent acquisition with business objectives. By cultivating employee engagement and professional growth, Anwar directly enhances operational efficiency and supports innovation within the company. Ultimately, Nisbat Anwar strengthens Renata Limited's human capital, driving organizational success and ensuring a robust talent pipeline for future growth.
Explore Leadership Teams in Manufacturing
BeOne Medicines is a global biotechnology company focused on developing next-generation cancer treatments through innovative research and cutting-edge therapies. The company is committed to making these treatments accessible to patients worldwide, emphasizing speed, equity, and affordability in delivering care. Guided by the principle that cancer knows no borders, BeOne Medicines operates with a global perspective, striving to expand the reach of life-saving therapies and improve outcomes for patients everywhere.
Company Leadership
SC
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Company Leadership GA
ZP
AH
DL
诺诚健华 is focused on developing innovative drugs to address significant unmet clinical needs in the fields of malignant tumors and autoimmune diseases. The company possesses comprehensive research and commercialization capabilities, aiming to create first-in-class or best-in-class therapies for global markets. With a strong pipeline in hematological malignancies, autoimmune diseases, and solid tumors, 诺诚健华 is committed to delivering high-quality innovative medicines that benefit patients worldwide. The company is led by co-founder and CEO Dr. 崔霁松, who emphasizes the importance of scientific-driven innovation.
Company Leadership NB
KG
SZ
Headquartered in Woodbury, Minnesota, Kindeva Drug Delivery is a leading global contract development and manufacturing organization (CDMO) in the pharmaceutical industry. Kindeva provides unique technologies and quality services to its customers, ranging from formulation and product development to commercial manufacturing. Kindeva focuses on complex drug programs, and its current offering spans inhalation drug delivery, transdermal drug delivery, microstructured transdermal systems (microsystems), and connected drug delivery.
Company Leadership BS
MC
DS
Frequently Asked Questions Regarding Renata Limited Top Executives and Leadership Team
